# Robert Lake

> Robert Lake is a venture - series unknown investor at Trinity Capital backing Health Care. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Trinity Capital](https://shizune.co/investors/profile/trinity-capital-investment)
- Location: San Diego, United States
- Total investments: 9
- Last investment: Mar 2026
- Lead investor: 89%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/roblakesd

Robert Lake is a venture - series unknown investor at Trinity Capital in San Diego focused on Health Care and Medical Device. Robert Lake is based out of San Diego, California, and is the senior managing director of life sciences of Trinity Capital. Robert previously worked at Runway Growth Capital as a managing director and head of life sciences.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 89% |
| Medical Device | 7 | 78% |
| Medical | 5 | 56% |
| Therapeutics | 2 | 22% |
| Pharmaceutical | 2 | 22% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 6 | 67% |
| Post-IPO Debt | 2 | 22% |
| Debt Financing | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 8 | 89% |
| United Kingdom | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Emboline | Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks. | $20M | Venture - Series Unknown | Mar 11, 2026 |  |
| Nalu Medical | Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California. | $50M | Venture - Series Unknown | Sep 16, 2025 |  |
| Rapid Micro Biosystems | Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to RapidMicro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts. | $45M | Post-IPO Debt | Aug 12, 2025 |  |
| CMR Surgical | CMR Surgical develops and manufactures robotic surgical systems designed to enhance precision and efficiency in minimally invasive surgery. Its primary product, Versius, is a versatile and modular robotic system that supports various surgical procedures.Versius is designed to mimic the human arm's flexibility while offering a compact andergonomic design. It integrates with hospital workflows and provides data-driven insights to support surgical performance. CMR Surgical collaborates with healthcare professionals to ensure that its technology meets clinical needs and improves patient outcomes. | $200M | Venture - Series Unknown | Apr 02, 2025 |  |
| Neuros Medical | Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine. | $25M | Venture - Series Unknown | Oct 31, 2023 |  |
| Revelle Aesthetics | Revelle Aesthetics features a team of the brightest and most passionate minds in the medical device and aesthetics industries. It was born from ExploraMed, a leading medtech incubator. | $30M | Venture - Series Unknown | Jun 01, 2023 |  |
| RxAnte | RxAnte provides predictive analytics and targeted clinical programs that improve medication prescribing and adherence for health plans and their members. A significant component to these clinical programs is RxAnte’s Mosaic Pharmacy Service, which provides a superior pharmacy experience to a health plan’s most complex and vulnerable members whileworking with their prescribers and caregivers to make regimens safer, simpler, and more affordable. | $15M | Venture - Series Unknown | Dec 20, 2022 |  |
| Allurion Technologies | Allurion Technologies is developing a medical device for weight loss that can be delivered and removed without surgery or endoscopy. | $25M | Debt Financing | Apr 06, 2021 |  |
| Ekso Bionics | Ekso Bionics is committed to applying the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable. Originally Berkeley Bionics, Ekso Bionics was founded in Berkeley, California in 2005. Since inception Ekso Bionics has forged partnerships with world-class institutions like UC Berkeley,received research grants from the Department of Defense and licensed technology to the Lockheed Martin Corporation. Today Ekso Bionics continues to pioneer the field of exoskeletons, designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human mobility and capability. | $10M | Post-IPO Debt |  |  |

9 of 9 investments shown.

## Co-investors
- [10X Capital](https://shizune.co/investors/profile/10x-capital) — VC Fund, 1 deal together
- [Windham Venture Partners](https://shizune.co/investors/profile/windham-venture-partners) — VC Fund, 1 deal together

## About Trinity Capital

VC Fund · Phoenix, United States

Trinity Capital is a provider of venture debt and equipment financings to emerging growth-stage companies. They work closely with venture capital firms, tech banks, and their respective portfolio companies to provide insightful and competitive venture debt financing solutions to address their customers’ specific needs. Having funded some of theworld’s most innovative start-up companies, they are the partner of choice for venture-backed technology start-ups seeking access to capital while preserving equity.

5 contacts available at Trinity Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Jason Hamlin | Director of Finance and Tax | https://shizune.co/investors/profile/jason-hamlin |
| Kevin Zeidan | Managing Director | https://shizune.co/investors/profile/kevin-zeidan |
| Kyle Brown | Chief Investment Officer and President | https://shizune.co/investors/profile/kyle-brown-4 |
| Robert Lake | Senior Managing Director, Life Sciences | https://shizune.co/investors/profile/robert-l-lake |
| Trin Coleman | Associate, Finance & Investor Relations | https://shizune.co/investors/profile/trin-coleman |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Robert Lake invest in?

Robert Lake invests primarily in Health Care, Medical Device and Medical startups, most often at Venture - Series Unknown and Post-IPO Debt stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Robert Lake last invest?

The most recent investment recorded for Robert Lake closed in Mar 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co